Gufic Biosciences Limited

NSE: GUFICBIO · Unclassified

₹430.35-0.94%06 Nov 2026

Ask the data

Instant answers about Gufic Biosciences Limited — computed from its filings, no language model

Market cap₹4,316 cr

Current price₹430.35

High / Low₹448 / ₹274

P/E193.4

P/B6.49

Book value₹66.3

ROE3.4%

ROCE13.0%

Debt / equity0.58

Dividend yield0.02%

EPS (TTM)₹2.22

Face value₹1

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY24	FY25	FY26
Revenue	806.7	819.8	944.0
EBITDA	145.9	134.7	151.3
Operating margin	18.1%	16.4%	16.0%
Interest	15.4	23.1	36.6
Depreciation	17.0	21.1	30.8
Profit before tax	115.7	94.1	86.5
Tax	29.5	24.5	22.3
Net profit	86.1	0.0	0.0
EPS ₹	8.74	6.95	6.40
Operating cash flow	-7.5	122.6	45.0
Capex	112.7	75.5	31.2
Dividend paid	1.0	1.0	1.0
Total assets	1,092.5	1,169.4	1,342.4
Equity	532.6	601.1	665.0

Quarterly performance

last 12 quarters · ₹ crore

showing latest 8 of 12 periods

	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	214.9	201.8	195.0	202.8	204.2	207.8	205.0	223.7	237.1	231.4	251.8	260.8
Operating profit	39.4	36.5	34.2	35.8	38.6	33.9	26.4	33.3	37.9	33.0	47.2	46.6
Operating margin	18.3%	18.1%	17.6%	17.6%	18.9%	16.3%	12.9%	14.9%	16.0%	14.3%	18.7%	17.9%
Other income	0.3	0.4	0.9	1.2	0.1	1.9	0.4	0.9	2.1	0.8	-1.2	0.5
Interest	4.5	3.2	3.6	4.6	5.2	4.9	8.4	9.2	9.6	8.4	9.4	9.3
Depreciation	4.3	4.1	4.3	4.3	4.3	4.6	7.8	7.7	7.8	7.7	7.7	7.7
Profit before tax	30.9	29.6	27.1	28.1	29.2	26.3	10.5	17.3	22.6	17.7	28.9	30.0
Tax	7.7	7.3	7.1	7.2	7.5	7.0	2.8	4.2	5.8	5.3	7.0	7.7
Net profit	23.2	22.3	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3
EPS ₹	2.39	2.23	2.00	2.08	2.17	1.93	0.77	1.30	1.68	1.24	2.18	2.22
Revenue YoY	—	—	—	—	-5.0%	3.0%	5.1%	10.3%	16.1%	11.4%	22.8%	16.6%
Profit YoY	—	—	—	—	-100.0%	-100.0%	-100.0%	—	—	—	—	—

Earlier results (standalone, Sep '07 – Jun '23)

₹ crore · from BSE, before the NSE XBRL filings begin

Gufic Biosciences Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 15 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†	FY20†	FY21†	FY22†	FY23†
Revenue	52.6	64.3	71.8	83.7	100.4	123.1	151.8	202.3	249.4	304.1	350.1	357.8	450.8	779.1	690.6
Operating profit	4.5	5.5	5.8	7.1	11.2	12.2	14.5	19.8	27.1	38.2	45.9	44.6	73.3	145.7	131.3
Operating margin	8.5%	8.6%	8.1%	8.5%	11.1%	9.9%	9.5%	9.8%	10.9%	12.6%	13.1%	12.5%	16.3%	18.7%	19.0%
Other income	0.2	0.3	0.3	0.4	0.2	0.5	0.4	0.5	0.8	3.0	4.5	6.8	4.5	3.1	2.6
Interest	2.5	2.2	2.1	2.6	3.8	3.9	4.5	5.4	6.2	8.9	10.2	12.7	13.2	4.8	7.6
Depreciation	1.5	1.7	1.7	1.9	2.2	2.5	3.9	3.8	3.7	4.3	4.6	8.3	12.5	17.1	19.6
Profit before tax	1.4	1.9	2.3	3.0	5.4	6.3	6.5	11.2	18.0	29.5	35.6	30.3	52.1	126.8	106.7
Tax	0.4	0.6	0.8	1.4	2.0	2.0	2.8	3.9	6.6	11.5	13.6	7.5	13.5	31.0	27.0
Net profit	1.0	1.3	1.5	1.5	3.3	4.3	3.8	7.3	11.4	18.1	22.0	22.9	38.6	95.8	79.7

Quarters

showing latest 8 of 64 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†	DEC '22†	MAR '23†	JUN '23†
Revenue	13.3	12.6	13.8	13.8	13.4	11.0	14.4	15.2	16.8	18.1	14.3	17.4	19.4	19.2	15.8	19.5	20.4	22.0	21.8	27.2	23.8	24.8	24.7	25.4	29.0	31.4	37.4	39.1	42.8	34.3	35.5	37.7	51.4	56.1	57.1	55.5	64.4	65.1	64.5	63.4	74.8	88.4	77.4	78.5	92.4	87.7	91.5	92.4	86.0	97.7	81.6	54.1	120.3	144.4	131.9	250.8	194.1	172.1	162.2	165.3	174.8	177.5	173.0	195.0
Operating profit	1.1	1.0	1.0	1.2	1.2	1.5	0.7	1.5	1.5	1.5	1.1	1.4	1.5	1.6	1.2	2.0	1.9	1.6	1.6	2.5	2.7	2.7	3.3	2.9	2.9	3.1	3.3	3.9	4.2	3.4	2.8	3.7	4.5	5.5	6.2	6.4	6.5	6.7	7.5	7.4	9.8	11.9	9.1	9.2	12.3	12.0	12.5	12.1	10.2	11.9	10.3	-0.6	25.6	24.5	23.8	45.6	35.8	32.7	31.5	33.2	32.6	33.4	32.1	35.5
Operating margin	8.1%	7.8%	7.4%	8.5%	8.7%	13.5%	4.6%	9.9%	8.7%	8.3%	7.5%	8.1%	7.8%	8.5%	7.7%	10.3%	9.1%	7.4%	7.5%	9.1%	11.2%	11.0%	13.3%	11.3%	10.0%	9.9%	8.9%	10.1%	9.9%	10.0%	8.0%	9.7%	8.7%	9.8%	10.8%	11.5%	10.1%	10.4%	11.7%	11.7%	13.0%	13.5%	11.7%	11.7%	13.3%	13.6%	13.7%	13.1%	11.8%	12.2%	12.6%	-1.1%	21.3%	16.9%	18.0%	18.2%	18.5%	19.0%	19.4%	20.1%	18.7%	18.8%	18.6%	18.2%
Other income	0.1	0.3	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.3	-0.1	-0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.8	0.6	1.4	0.2	0.7	0.2	3.3	1.0	1.6	3.1	1.1	1.0	2.2	0.6	0.7	1.2	0.3	1.5	0.0	0.4	0.8	0.8	0.6	0.9
Interest	0.4	0.4	0.4	0.4	0.5	0.7	1.0	0.5	0.4	0.8	0.5	0.4	0.4	0.6	0.7	0.7	0.6	0.5	0.8	0.6	0.8	0.9	1.5	1.0	0.9	1.0	1.0	1.1	1.1	1.0	1.3	1.1	1.2	1.4	1.6	1.4	1.4	1.5	2.0	1.8	2.7	1.7	2.7	1.9	2.5	2.4	3.4	2.8	3.5	3.5	3.0	3.2	3.4	3.7	2.9	1.2	1.6	1.0	1.1	0.9	1.6	2.2	2.9	4.1
Depreciation	0.4	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.6	0.6	0.6	0.6	0.7	1.0	1.0	1.1	0.8	0.9	0.9	1.0	0.9	0.9	0.9	0.9	0.9	0.9	1.0	1.1	1.2	0.9	1.0	1.1	1.6	1.2	2.6	2.1	2.4	2.3	2.5	3.2	4.5	4.1	4.2	4.5	4.3	4.4	4.6	4.7	5.9	4.2
Profit before tax	0.4	0.4	0.6	0.5	0.3	0.5	0.2	0.6	0.6	0.4	0.3	0.7	0.7	0.6	0.4	0.9	0.7	0.6	0.7	1.4	1.4	1.3	1.3	1.2	1.5	1.6	2.0	2.2	2.0	1.4	1.0	1.6	2.6	3.3	3.7	4.2	4.2	4.4	5.3	5.9	7.5	9.7	6.5	6.5	9.5	8.8	10.8	9.2	5.7	9.4	6.1	-5.1	22.0	18.2	17.1	41.5	30.4	28.7	26.2	28.3	27.3	27.2	23.9	28.1
Tax	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.6	0.5	0.5	0.5	0.6	0.4	0.4	0.5	0.7	1.0	0.8	0.7	0.3	0.6	1.0	0.9	1.4	1.6	1.6	1.3	2.1	2.3	1.8	3.9	3.5	2.6	3.3	2.9	4.7	2.4	1.4	2.4	1.4	-1.4	5.7	5.0	4.2	10.3	7.0	7.7	5.9	7.2	7.0	6.9	5.8	7.4
Net profit	0.3	0.3	0.3	0.4	0.2	0.4	0.0	0.4	0.4	0.2	0.3	0.4	0.5	0.4	0.2	0.6	0.5	0.4	0.1	0.9	0.9	0.8	0.7	0.8	1.1	1.1	1.3	1.2	1.2	0.7	0.7	1.0	1.6	2.4	2.2	2.5	2.6	3.1	3.1	3.5	5.7	5.8	3.0	3.9	6.2	5.9	6.0	6.8	4.3	7.0	4.7	-3.8	16.3	13.2	12.9	31.2	23.3	21.0	20.3	21.1	20.2	20.3	18.1	20.6
EPS ₹	0.04	0.04	0.04	0.05	0.03	0.05	—	0.05	0.05	0.03	0.03	0.05	0.06	0.05	0.03	0.07	0.06	0.05	0.01	0.11	0.11	0.11	0.09	0.10	0.15	0.14	0.16	0.15	0.15	0.09	0.09	0.13	0.21	0.31	0.29	0.33	0.34	0.40	0.40	0.46	0.73	0.75	0.39	0.51	0.79	0.76	0.77	0.88	0.55	0.90	0.61	-0.48	2.10	1.69	1.33	3.22	2.41	2.17	2.09	2.17	2.09	2.10	1.87	2.13
Revenue YoY	—	—	—	—	0.8%	-13.0%	4.6%	10.2%	24.6%	65.2%	-1.1%	14.9%	15.7%	6.1%	10.5%	12.0%	5.0%	14.4%	38.2%	39.5%	16.7%	12.6%	13.2%	-6.8%	22.2%	26.6%	51.5%	54.0%	47.3%	9.5%	-4.8%	-3.6%	20.3%	63.4%	60.6%	47.2%	25.2%	16.0%	13.0%	14.4%	16.2%	35.9%	20.0%	23.8%	23.5%	-0.9%	18.3%	17.7%	-6.9%	11.5%	-10.9%	-41.4%	39.9%	47.7%	61.7%	363.2%	61.3%	19.1%	22.9%	-34.1%	-9.9%	3.1%	6.7%	18.0%
Profit YoY	—	—	—	—	-7.4%	20.0%	-97.1%	2.8%	64.0%	-36.1%	2500.0%	13.5%	17.1%	78.3%	-23.1%	38.1%	-2.1%	-4.9%	-55.0%	51.7%	89.4%	117.9%	688.9%	-9.1%	29.2%	25.9%	77.5%	48.7%	3.5%	-36.4%	-44.4%	-12.6%	38.7%	255.9%	215.7%	145.2%	60.0%	28.1%	41.2%	38.8%	114.8%	88.4%	-3.5%	11.0%	9.2%	0.7%	99.7%	73.3%	-30.5%	19.4%	-21.5%	-155.1%	279.8%	87.7%	172.7%	—	42.9%	59.6%	57.4%	-32.6%	-13.4%	-3.3%	-10.6%	-2.0%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 9 periods

	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
ROE	12.3%	7.4%	3.5%	0.0%	0.0%	0.0%	0.0%	0.0%	3.4%
ROCE	15.5%	15.2%	15.0%	12.9%	12.2%	11.1%	10.6%	11.7%	13.0%
Net margin	8.0%	5.3%	2.5%	0.0%	0.0%	0.0%	0.0%	0.0%	2.3%
EBITDA margin	17.9%	18.1%	17.6%	16.4%	15.7%	15.0%	14.5%	16.0%	16.8%
Debt / equity	0.60	0.49	0.49	0.52	0.52	0.55	0.55	0.58	0.58
Interest coverage	8.27	7.86	7.03	5.07	4.01	3.39	2.91	3.36	3.71
Asset turnover	0.75	0.73	0.73	0.70	0.72	0.69	0.71	0.70	0.73

Balance sheet

equity vs borrowings over time · ₹ crore

	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	9.7	10.0	10.0	10.0	10.0	10.0
Other equity / reserves	381.0	522.5	564.1	591.0	621.1	654.9
Total equity	390.7	532.6	574.2	601.1	631.1	665.0
Borrowings	339.2	317.0	283.6	310.4	346.4	385.2
Current liabilities	378.2	372.1	354.2	387.6	469.7	517.9
Non-current liabilities	200.6	187.9	176.2	180.7	170.3	159.5
Total assets	969.4	1,092.5	1,104.7	1,169.4	1,271.1	1,342.4
Property, plant & equipment	164.6	153.3	142.9	499.6	488.7	484.9
Capital work-in-progress	257.6	307.1	363.2	21.8	24.1	22.1
Investments	0.8	1.8	1.8	1.8	1.8	1.8
Inventories	192.2	200.5	186.8	216.9	229.7	324.5
Receivables	265.0	329.9	310.8	314.6	324.0	297.4
Cash & equivalents	4.3	1.1	5.7	15.7	74.6	62.2

Cash flow

annual · ₹ crore · line = free cash flow

	FY24	FY25	FY26
Cash from operations	-7.5	122.6	45.0
Cash from investing	-102.4	-70.8	-31.0
Cash from financing	82.4	-37.2	32.5
Capex	112.7	75.5	31.2
Free cash flow	-120.2	47.0	13.8
Dividends paid	1.0	1.0	1.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹484.9 cr36%

CWIP

₹22.1 cr2%

Investments

₹1.8 cr0%

Inventories

₹324.5 cr24%

Receivables

₹297.4 cr22%

Cash & equivalents

₹62.2 cr5%

Other assets

₹149.5 cr11%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Gufic Biosciences Limited	4,316	430.35	193.4	6.49	3.4%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+1.8%

6 months+43.9%

1 year+29.4%

3Y CAGR+17.6%

5Y CAGR+18.3%

10Y CAGR+24.1%

50-day avg₹421.18

200-day avg₹355.52

RSI (14)65

FAQs

What is the share price of Gufic Biosciences Limited?

Gufic Biosciences Limited (GUFICBIO) closed at ₹430.35 on NSE on 06 Nov 2026.

What is the market cap of Gufic Biosciences Limited?

₹4,316 crore at the latest close.

What is the P/E ratio of Gufic Biosciences Limited?

193.4, on trailing-twelve-month earnings from its filings.

How fast is Gufic Biosciences Limited growing?

Gufic Biosciences Limited: Latest-quarter revenue is up 16.6% year on year.

How profitable is Gufic Biosciences Limited?

On a trailing-twelve-month basis return on equity is 3.4%, return on capital employed 13.0%, operating margin 16.8%, net margin 2.3%.

How much debt does Gufic Biosciences Limited have?

Gufic Biosciences Limited is moderately geared: debt to equity is 0.58 with borrowings of ₹385 cr against cash of ₹62 cr (balance sheet of 2026-03-31). Operating profit covers interest 3.7 times.

Financials parsed from Gufic Biosciences Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '23, annual from FY24, balance sheet from Sep '23. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.